| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Morepen Laboratories Limited (NSE: MOREPENLAB)
MOREPENLAB Technical Analysis
4
| As on 24th Apr 2024 MOREPENLAB SHARE Price closed @ 51.15 and we RECOMMEND Strong Buy for LONG-TERM with Stoploss of 39.63 & Buy for SHORT-TERM with Stoploss of 48.13 we also expect STOCK to react on Following IMPORTANT LEVELS. |
MOREPENLABSHARE Price
| Open | 51.80 | Change | Price | % |
| High | 53.15 | 1 Day | -0.65 | -1.25 |
| Low | 51.00 | 1 Week | 5.00 | 10.83 |
| Close | 51.15 | 1 Month | 8.05 | 18.68 |
| Volume | 4185477 | 1 Year | 25.25 | 97.49 |
| 52 Week High 53.20 | 52 Week Low 23.85 | ||||
NSE INDIA Most Active Stocks
| IDEA | 13.10 | -9.03% |
| SAIL | 164.65 | 8.14% |
| YESBANK | 25.45 | -0.78% |
| TATASTEEL | 165.55 | 2.73% |
| IRFC | 149.00 | 0.85% |
| SOUTHBANK | 29.10 | 1.04% |
| MRPL | 248.70 | 10.75% |
| SUZLON | 41.80 | -0.12% |
| BEL | 236.50 | 0.92% |
| RAMASTEEL | 14.00 | 2.56% |
NSE INDIA Top Gainers Stocks
| ROML | 63.05 | 19.98% |
| COMPUSOFT | 35.20 | 19.93% |
| SHRADHA | 78.55 | 19.83% |
| STEELCITY | 102.95 | 19.78% |
| WEIZMANIND | 142.25 | 19.59% |
| TEMBO | 240.90 | 18.61% |
| CHENNPETRO | 1075.00 | 15.82% |
| YUKEN | 1180.65 | 13.81% |
| ORIENTCEM | 230.50 | 12.85% |
| AEGISCHEM | 604.50 | 12.41% |
NSE INDIA Top Losers Stocks
| MOREPENLAB Daily Charts |
MOREPENLAB Intraday Charts |
Whats New @ Bazaartrend |
MOREPENLAB Free Analysis |
|
|
MOREPENLAB Important Levels Intraday
| RESISTANCE | 55.29 |
| RESISTANCE | 53.96 |
| RESISTANCE | 53.14 |
| RESISTANCE | 52.32 |
| SUPPORT | 49.98 |
| SUPPORT | 49.16 |
| SUPPORT | 48.34 |
| SUPPORT | 47.01 |
MOREPENLAB Target April 2024
| 4th UP Target | 74.25 |
| 3rd UP Target | 66.22 |
| 2nd UP Target | 61.25 |
| 1st UP Target | 56.29 |
| 1st DOWN Target | 42.12 |
| 2nd DOWN Target | 37.15 |
| 3rd DOWN Target | 32.18 |
| 4th DOWN Target | 24.15 |
MOREPENLAB Weekly Target
| 4th UP Target | 61.96 |
| 3rd UP Target | 57.82 |
| 2nd UP Target | 55.26 |
| 1st UP Target | 52.70 |
| 1st DOWN Target | 45.40 |
| 2nd DOWN Target | 42.84 |
| 3rd DOWN Target | 40.28 |
| 4th DOWN Target | 36.14 |
MOREPENLAB Target2024
| 4th UP Target | 105.11 |
| 3rd UP Target | 86.97 |
| 2nd UP Target | 75.76 |
| 1st UP Target | 64.55 |
| 1st DOWN Target | 32.55 |
| 2nd DOWN Target | 21.34 |
| 3rd DOWN Target | 10.13 |
| 4th DOWN Target | -8.01 |
Morepen Laboratories Limited ( NSE INDIA Symbol : MOREPENLAB )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
MOREPENLAB Synopsis Technicals View
| 50 Day EMA |
Close is Above EMA 50 (Short Term) |
Bullish | |
| 100 Day EMA | Close is Above EMA 100 (Mid Term) | Bullish | |
| 200 Day EMA | Close is Above EMA 200 (Long Term) | Bullish | |
| MACD (12 26 9) | MACD Line is Less Then SIGNAL Line | Bearish | |
| RSI (14) | RSI is Below 30 | Over Sold | |
| MFI (14) | MFI is 24.90 | Sideways | |
| CCI (20) | CCI is -92.64 | Sideways | |
| WILLIAM %R (14) | William %R is Below -80 | Over Sold | |
| ADX (14) | ADX is Above 20 & +DI is Below -DI | Down Trend | |
| PSAR | Stoploss For Long Buy | 10.40 | |
| 10 Day Avg Volume | Traded -42.69 % Less then 10 Day Average Volume | ||
MOREPENLAB Other Details
| Segment | EQ | |
| Market Capital | 24385087488.00 | |
| Sector | Healthcare | |
| Industry | Drug Manufacturers-Specialty & Generic | |
| Offical website | > | |
MOREPENLAB Address
 |
||
MOREPENLAB Latest News
MOREPENLAB Business Profile
Morepen Laboratories Limited develops, manufactures, markets, and sells active pharmaceutical ingredients (APIs), branded and generic formulations, and home health products in India. The company offers APIs for anti-histaminic, anti-asthmatic, anti-hypercholesterolemic, anti-hypertensive, and anti-diabetic drugs; point of care and medical devices; and home diagnostic products, such as air purifiers, thermometers, stethoscopes, blood pressure monitors, pulse-oximeters, nebulizers, glucometers, strips, sanitizers, disinfectant solutions, masks and gloves, and others. It also provides Burnol, a burn cream; Lemolate for cough and cold; and Fiber-X, a sat isabgol; and formulations for gastro, antibiotics, vitamins, nutritional, and anti-diabetics, as well as cardiac. In addition, the company is involved in the product contract manufacturing and brand sharing businesses; and provision of over-the-counter products under the Dr. Morepen brand. It exports its products to approximately 75 countries. Morepen Laboratories Limited was incorporated in 1984 and is based in New Delhi, India. Address: 409, Antriksh Bhawan, New Delhi, India, 110001
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service